Skip to main content

Table 2 Clinical markers of HIV infected children in Addis Ababa, Ethiopia, [N = 390] April 2008

From: Adherence to highly active antiretroviral therapy and its correlates among HIV infected pediatric patients in Ethiopia

Variable

Frequency(percentage)

p-value

 

adherent

Non-adherent

 

WHO Clinical stage of HIV disease

  

0.226

   Stage I

14(4.13)

1(2)

 

   Stage II

102(30.1)

9(17.6)

 

   Stage III

163(48.07)

30(58.8)

 

   Stage IV

60(17.7)

11(21.6)

 

CD4 counts at start of treatment

  

0.377

   <200

164(48.4)

30(58.8)

 

   200–499

131(38.6)

16(31.4)

 

   > = 500

44(13)

5(9.8)

 

Current CD4 count

  

0.073

   <200

45(13.3)

12(23.5)

 

   200–499

119(35.1)

20(39.2)

 

   > = 500

175(51.6)

19(37.3)

 

Regimen recommended

  

0.105

   4a = d4T/3TC/NVP

103(30.4)

16(31.4)

 

   4b = d4T/3TC/EFV

53(15.6)

9(17.6)

 

   4c = AZT/3TC/NVP

97(28.6)

7(13.7)

 

   4d = AZT/3TC/EFV

86(25.4)

19(37.3)

 
  1. d4T = Stavudine, 3TC = Lamivudine, NVP = Nevirapine, AZT = Zidovudine, EFV = Efavirenz